Double Stranded Development Milestones. Alnylam, its Affiliates or sublicensees (except Naked Sublicensees) will pay to Isis the following milestone payments for each Alnylam Double Stranded RNA Product within [***]days after the first achievement of each of the following events: Initiation of Phase I Trial US$375,000 Initiation of Phase III Trial US$750,000 Filing NDA US$[***] Marketing Approval US$[***] Each milestone payment under this Section 7.3(c) will only be due on the [***] Alnylam Double Stranded RNA Product that modulates a particular RNA Target to trigger such milestone payment, whether such milestone is achieved by Alnylam or an Affiliate or sublicensee of Alnylam. Notwithstanding the foregoing, the provisions of this Section 7.3(c) shall not apply to any Agricultural Field Product.
Appears in 1 contract
Samples: Strategic Collaboration and License Agreement (Isis Pharmaceuticals Inc)
Double Stranded Development Milestones. Alnylam, its Affiliates or sublicensees (except Naked Sublicensees) will pay to Isis the following milestone payments for each Alnylam Double Stranded RNA Product within [***]] days after the first achievement of each of the following events: Initiation of Phase I Trial US$US$ 375,000 Initiation of Phase III Trial US$US$ 750,000 Filing NDA US$US$ [***] Marketing Approval US$US$ [***] Each milestone payment under this Section 7.3(c) will only be due on the [***] Alnylam Double Stranded RNA Product that modulates a particular RNA Target to trigger such milestone payment, whether such milestone is achieved by Alnylam or an Affiliate or sublicensee of Alnylam. Notwithstanding the foregoing, the provisions of this Section 7.3(c) shall not apply to any Agricultural Field Product.
Appears in 1 contract
Samples: Strategic Collaboration and License Agreement (Alnylam Pharmaceuticals, Inc.)
Double Stranded Development Milestones. Alnylam, its Affiliates or sublicensees (except Naked Sublicensees) will pay to Isis the following milestone payments for each Alnylam Double Stranded RNA Product within [***]days ] [***] after the first achievement of each of the following events: Initiation of Phase I Trial US$375,000 [***] Initiation of Phase III Trial US$750,000 [***] Filing NDA US$[***] Marketing Approval US$[***] Each milestone payment under this Section 7.3(c) will only be due on the [***] Alnylam Double Stranded RNA Product that modulates a particular RNA Gene Target to trigger such milestone payment, whether such milestone is achieved by Alnylam or an Affiliate or sublicensee of Alnylam. Notwithstanding the foregoing, the provisions of this Section 7.3(c) shall not apply to any Agricultural Field Product.
Appears in 1 contract
Samples: Strategic Collaboration and License Agreement (Isis Pharmaceuticals Inc)
Double Stranded Development Milestones. Alnylam, its Affiliates or sublicensees (except Naked Sublicensees) will pay to Isis the following milestone payments for each Alnylam Double Stranded RNA Product within [***]days ] after the first achievement of each of the following events: Initiation of Phase I Trial US$375,000 [**] Initiation of Phase III Trial US$750,000 [**] Filing NDA US$[***] Marketing Approval US$[***] Each milestone payment under this Section 7.3(c) will only be due on the [***] Alnylam Double Stranded RNA Product that modulates a particular RNA Gene Target to trigger such milestone payment, whether such milestone is achieved by Alnylam or an Affiliate or sublicensee of Alnylam. Notwithstanding the foregoing, the provisions of this Section 7.3(c) shall not apply to any Agricultural Field Product.
Appears in 1 contract
Samples: Strategic Collaboration and License Agreement (Alnylam Pharmaceuticals, Inc.)